Invesco Ltd. Rubius Therapeutics, Inc. Transaction History

Invesco Ltd.

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.79 - $5.98 $16,627 - $125,861	-21,047 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.25 - $10.4 $1,602 - $3,920	377 Added 1.82%	21,047 $116,000
Q4 2021 Feb 14, 2022	SELL	$9.68 - $17.74 $46,531 - $85,276	-4,807 Reduced 18.87%	20,670 $199,000
Q3 2021 Nov 15, 2021	BUY	$17.6 - $25.91 $66,721 - $98,224	3,791 Added 17.48%	25,477 $455,000
Q2 2021 Aug 17, 2021	BUY	$22.26 - $28.43 $269,902 - $344,713	12,125 Added 126.82%	21,686 $530,000
Q1 2021 May 17, 2021	SELL	$8.02 - $32.01 $129,523 - $516,961	-16,150 Reduced 62.81%	9,561 $253,000
Q4 2020 Feb 16, 2021	BUY	$4.23 - $8.73 $21,962 - $45,326	5,192 Added 25.3%	25,711 $195,000
Q3 2020 Nov 16, 2020	SELL	$4.65 - $6.25 $2,329 - $3,131	-501 Reduced 2.38%	20,519 $102,000
Q2 2020 Aug 14, 2020	SELL	$4.01 - $6.88 $8,613 - $14,778	-2,148 Reduced 9.27%	21,020 $126,000
Q1 2020 May 15, 2020	SELL	$3.74 - $9.84 $1.33 Million - $3.5 Million	-356,038 Reduced 93.89%	23,168 $103,000
Q2 2019 Aug 14, 2019	BUY	$13.5 - $19.94 $337 - $498	25 Added 0.01%	379,206 $5.97 Million
Q1 2019 May 15, 2019	SELL	$13.27 - $18.51 $4,299 - $5,997	-324 Reduced 0.09%	379,181 $6.86 Million
Q4 2018 Feb 14, 2019	BUY	$13.83 - $22.97 $5.25 Million - $8.72 Million	379,505 New	379,505 $6.1 Million

325

Ticker RUBY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,357,000
Description
Rubius Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of red cell therapeutics (RCTs) for the treatment of patients with severe diseases. The company is developing RTX-240 and RTX-224 for the treatment of solid tumors cancer; and RTX-aAPC to treat cancers. It is also developing RTX-321 for the treatmen...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.